K. Murray

发表

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.

W. Powlis, D. Nelson, W. Curran, 1993, International journal of radiation oncology, biology, physics.

Echographic monitoring of response of extraocular muscles to irradiation in Graves' ophthalmopathy.

G J Harris, B. Erickson, B A Erickson, 1995, International journal of radiation oncology, biology, physics.

Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases.

W Curran, W. Curran, L. Gaspar, 2000, International journal of radiation oncology, biology, physics.

A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.

Michael I. Seider, W. Curran, B. Movsas, 1997, International journal of radiation oncology, biology, physics.

Role of the extent of prophylactic regional lymph node radiotherapy on survival in high‐risk neuroblastoma: A report from the COG A3973 study

K. Matthay, D. von Allmen, L. Diller, 2019, Pediatric blood & cancer.

Response to paclitaxel, topotecan, and topotecan-cyclophosphamide in children with untreated disseminated neuroblastoma treated in an upfront phase II investigational window: a pediatric oncology group study.

W. London, P. Thorner, R. Marcus, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Event-free survival of children with biologically favourable neuroblastoma based on the degree of initial tumour resection: results from the Pediatric Oncology Group.

E. Halperin, R. Shamberger, D. Strother, 1997, European journal of cancer.

Stage I and II Hodgkin's disease in the pediatric population. Long-term follow-up of patients staged predominantly clinically.

C. Schultz, J. Wilson, K. Murray, 1996, American journal of clinical oncology.

RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database.

E. Shaw, W. Curran, M. Mehta, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Importance of histologic condition and treatment of pediatric cerebellar astrocytoma

K. Murray, L. Kun, P. Conway, 1991 .

Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.

R. Abrams, B. Fisher, C. Scott, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prostate cancer: are racial differences in clinical stage and survival explained by differences in symptoms?

C. Lawton, R. Byhardt, J. Wilson, 1994, Radiology.

Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of radiation therapy oncology group 89-03.

B. Donnelly, W. Shipley, C. Perez, 1998, The Journal of urology.

A phase II trial of weekly paclitaxel and conventional radiotherapy for supratentorial glioblastoma multiforme: RTOG 96-02

B. Movsas, C. Langer, C. Scott, 1998 .

Lung cancer treated on the basis of cytologic findings: An analysis of 112 patients

L. Clowry, K. Murray, J. Caya, 1990, Diagnostic cytopathology.

High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes.

B. Erickson, S. Firat, K. Murray, 2001, International journal of radiation oncology, biology, physics.

Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results.

J. Cox, M. Goswitz, C. Schultz, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is long‐term survival possible with external beam irradiation for stage D1 adenocarcinoma of the prostate?

J. Cox, C. Lawton, R. Byhardt, 1992, Cancer.

Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.

R. Truitt, L. Baxter‐Lowe, B. Camitta, 1990, The New England journal of medicine.

Vascular Density Has Prognostic Value in Merkel Cell Carcinoma

K. Murray, T. Beer, L. Ng, 2008, The American Journal of dermatopathology.

N. Flomenberg, L. Baxter‐Lowe, D. Margolis, 1996, British journal of haematology.

L. True, B. Donnelly, W. Shipley, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cytofluorometric analysis of the DNA content in ovarian carcinoma and its relationship to patient survival

L. Hopwood, J. Wilson, K. Murray, 1989, Cancer.

Mast Cells Have Prognostic Value in Merkel Cell Carcinoma

K. Murray, T. Beer, L. Ng, 2008, The American Journal of dermatopathology.

Late renal dysfunction in adult survivors of bone marrow transplantation

C. Lawton, E. Cohen, J. Moulder, 1991, Cancer.

Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme.

W. Curran, B. Movsas, C. Langer, 2001, International journal of radiation oncology, biology, physics.

Continuous split course irradiation for stage I and II Hodgkin's disease: 20 year experience at the Medical College of Wisconsin.

J. Cox, C. Schultz, J. Wilson, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate.

G. Hanks, K. Winter, M. Machtay, 2001, International journal of radiation oncology, biology, physics.

Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effects.

B. Erickson, W. Mieler, M. Gillin, 1996, International journal of radiation oncology, biology, physics.

Influence of renal shielding on the incidence of late renal dysfunction associated with T-lymphocyte deplete bone marrow transplantation in adult patients.

C. Lawton, E. Cohen, J. Moulder, 1992, International journal of radiation oncology, biology, physics.

Osteoblastoma response to chemotherapy

K. Unni, K. Murray, B. Camitta, 1991, Cancer.

Bone marrow transplantation for children with severe aplastic anemia: use of donors other than HLA-identical siblings.

B. Camitta, K. Murray, J. Casper, 1989, Blood.

Periocular lymphoproliferative diseases: natural history, prognostic factors, and treatment.

B. Erickson, C. Enke, J. Wilson, 1992, Radiology.

Outcomes of the POG 9340/9341/9342 trials for children with high‐risk neuroblastoma: A report from the Children's Oncology Group

Yang Zhang, W. London, P. Zage, 2008, Pediatric blood & cancer.

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.

N. Petrelli, S. Doggett, T. Pajak, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315.

D. Nelson, J. Nelson, H. Bonner, 1992, International journal of radiation oncology, biology, physics.

Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature.

J. Cox, K. Murray, L. Kun, 1986, Journal of neurosurgery.

Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04.

W. Curran, W. Regine, C. Scott, 2001, International journal of radiation oncology, biology, physics.

L. Baxter‐Lowe, B. Camitta, N. Bunin, 1995, Blood.

Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83‐02

D. Nelson, L. Gaspar, W. Curran, 1996, Cancer.

Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group.

J. Cooper, J. Paradelo, A. Russell, 1991, International journal of radiation oncology, biology, physics.

Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.

J. Maris, K. Matthay, H. Shimada, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Central pathology review in clinical trials for patients with malignant glioma. A report of radiation therapy oncology group 83‐02

D. Nelson, W. Curran, L. Gaspar, 1995, Cancer.

Allogeneic marrow transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblings.

B. Camitta, N. Bunin, K. Murray, 1992, Bone marrow transplantation.

Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02.

A. Markoe, D. Nelson, J. Earle, 1997, International journal of radiation oncology, biology, physics.

Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04.

J. Michalski, B. Movsas, C. Scott, 2000, International journal of radiation oncology, biology, physics.

Improved dose localization with dual energy photon irradiation in treatment of lateralized intracranial malignancies.

M. Gillin, N. Janjan, J. Wilson, 1991, International journal of radiation oncology, biology, physics.

Pediatric sensorineural hearing loss after temporal bone radiation.

D. Beste, K. Murray, R. Fong, 1995, The American journal of otology.

Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.

D. Brat, W. Curran, M. Mehta, 2004, Neuro-oncology.

Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02.

W. Curran, T. Phillips, J. Schwade, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Technical modifications in hyperfractionated total body irradiation for T-lymphocyte deplete bone marrow transplant.

M. Gillin, C. Lawton, J. Wilson, 1989, International journal of radiation oncology, biology, physics.

Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL

D. Margolis, B. Camitta, M. Eapen, 2006, Bone Marrow Transplantation.

Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02.

D. Nelson, W. Curran, C. Scott, 1995, International journal of radiation oncology, biology, physics.

DNA content in nasopharyngeal carcinoma.

L. Hopwood, B. Campbell, L. Clowry, 1990, American journal of otolaryngology.

Prognosis for breast cancer surgery and radiation therapy compared with mastectomy alone. A retrospective analysis of 759 patients with stage I/II breast cancer

N. Janjan, J. Wilson, K. Murray, 1992, Cancer.

A randomized trial of accelerated hyperfractionated radiation therapy and bis‐chlorethyl nitrosourea for malignant glioma. A preliminary report of radiation therapy oncology group 83–02

W. Powlis, D. Nelson, W. Curran, 1992, Cancer.

Prophylactic cranial irradiation (PCI) for selected lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial

J. Cooper, J. Paradelo, A. Russell, 1990 .

Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.

M. Prados, W. Curran, P. Rubin, 1998, International journal of radiation oncology, biology, physics.

Neurocognitive outcome in brain metastasis patients treated with accelerated fractionation (AF) vs. accelerated hyperfractionation (AH) whole brain radiotherapy (WBRT): An analysis from radiation therapy oncology group (RTOG) study 91-04

W. Curran, W. Regine, C. Scott, 2000 .

The role of photodynamic therapy in posterior fossa brain tumors. A preclinical study in a canine glioma model.

J E Moulder, Meic H. Schmidt, H. Whelan, 1993, Journal of neurosurgery.

Tolerance to Propofol Generally Does Not Develop in Pediatric Patients Undergoing Radiation Therapy

D. Rosner, R. Berens, K. Murray, 1996, Anesthesiology.

Importance of histologic condition and treatment of pediatric cerebellar astrocytoma

K. Murray, L. Kun, P. Conway, 1991, Cancer.